It’s becoming more and more difficult for Western companies to make their way into this competitive market.
Here’s a hint: Compliance with new regulation in Europe is a high priority.
The need is growing for life-saving treatments.
Changes in financial reporting can be an annual disruption for medical device companies. But the impact of recent changes to financial accounting standards is likely the most sweeping since the passage of the Sarbanes Oxley Act of 2002.
The company just announced that it is restructuring its global supply chain.
No longer just the domain of bitcoin pundits and tech cowboys, blockchain technology has very real implications for the healthcare ecosystem—if we’re willing to give it a go.
Although healthcare industry tends to be slow to adopt new technologies, device companies should seriously consider the potential of blockchain.
The president’s tariffs on imports, especially steel and aluminum, could increase input production costs, making products more expensive.
Innovations are helping companies to maintain compliance while driving operational gains across their supply chain.
Excessive focus on compliance can create hurdles in cultivating quality and innovation.